170 related articles for article (PubMed ID: 26105582)
1. Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1/fetuin A axis.
Noureldein MH; Abd El-Razek RS; El-Hefnawy MH; El-Mesallamy HO
Diabetes Res Clin Pract; 2015 Sep; 109(3):513-20. PubMed ID: 26105582
[TBL] [Abstract][Full Text] [Related]
2. Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus.
Zhou ZW; Ju HX; Sun MZ; Chen HM; Fu QP; Jiang DM
Clin Chim Acta; 2018 Jan; 476():98-102. PubMed ID: 29174342
[TBL] [Abstract][Full Text] [Related]
3. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers.
El-Deeb TS; Bakkar SM; Eltoony L; Zakhary MM; Kamel AA; Nafee AM; Hetta HF
Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011
[TBL] [Abstract][Full Text] [Related]
4. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
[TBL] [Abstract][Full Text] [Related]
5. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment.
Haluzík MM; Anderlová K; Doležalová R; Adamíková A; Haluzíková D; Housová J; Svacina S; Haluzík M
Physiol Res; 2009; 58(1):93-99. PubMed ID: 18198986
[TBL] [Abstract][Full Text] [Related]
6. Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.
Yang PJ; Ser KH; Lin MT; Nien HC; Chen CN; Yang WS; Lee WJ
Obes Surg; 2015 Dec; 25(12):2328-34. PubMed ID: 25933632
[TBL] [Abstract][Full Text] [Related]
7. Is rationale to decrease serum osteoprotegerin and fetuin-A in type 2 diabetes mellitus patients?
Berezin A
Diabetes Metab Syndr; 2016; 10(3):169-70. PubMed ID: 26869171
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
9. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.
Zhou ZW; Ju HX; Sun MZ; Fu QP; Chen HM; Ji HB; Ji F; Jiang DM
Clin Chim Acta; 2016 Apr; 455():113-7. PubMed ID: 26851648
[TBL] [Abstract][Full Text] [Related]
10. Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: the influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment.
Kavalkova P; Touskova V; Roubicek T; Trachta P; Urbanova M; Drapalova J; Haluzikova D; Mraz M; Novak D; Matoulek M; Lacinova Z; Haluzik M
Horm Metab Res; 2013 Oct; 45(11):820-6. PubMed ID: 23979788
[TBL] [Abstract][Full Text] [Related]
11. Serum fetuin-A and arginase-1 in human obesity model: Is there any interaction between inflammatory status and arginine metabolism?
Tanrikulu-Küçük S; Koçak H; Öner-İyidoğan Y; Seyithanoğlu M; Topparmak E; Kayan-Tapan T
Scand J Clin Lab Invest; 2015 Jul; 75(4):301-7. PubMed ID: 25723054
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial.
Esteghamati A; Afarideh M; Feyzi S; Noshad S; Nakhjavani M
Diabetes Metab Syndr; 2015; 9(4):258-65. PubMed ID: 25450818
[TBL] [Abstract][Full Text] [Related]
13. Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients.
Ozyazgan S; Karaoglu K; Kurt A; Altinok A; Konukoglu D; Osar Siva Z; Andican G
Minerva Med; 2013 Jun; 104(3):287-93. PubMed ID: 23748282
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Lactobacillus casei on Glycemic Response, Serum Sirtuin1 and Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Khalili L; Alipour B; Asghari Jafar-Abadi M; Faraji I; Hassanalilou T; Mesgari Abbasi M; Vaghef-Mehrabany E; Alizadeh Sani M
Iran Biomed J; 2019 Jan; 23(1):68-77. PubMed ID: 29803203
[TBL] [Abstract][Full Text] [Related]
15. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation.
Powell LA; Crowe P; Kankara C; McPeake J; McCance DR; Young IS; Trimble ER; McGinty A
Clin Sci (Lond); 2012 Aug; 123(3):135-46. PubMed ID: 22309242
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men.
Ryan KE; McCance DR; Powell L; McMahon R; Trimble ER
Atherosclerosis; 2007 Oct; 194(2):e123-30. PubMed ID: 17145061
[TBL] [Abstract][Full Text] [Related]
17. [Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes].
Zhu HL; Yu RM; Huang XZ; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1050-1. PubMed ID: 18583261
[TBL] [Abstract][Full Text] [Related]
18. PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.
Feng X; Gao X; Jia Y; Zhang H; Xu Y; Wang G
Med Sci Monit; 2016 Mar; 22():743-51. PubMed ID: 26944934
[TBL] [Abstract][Full Text] [Related]
19. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation.
Khadir A; Kavalakatt S; Madhu D; Hammad M; Devarajan S; Tuomilehto J; Tiss A
Lipids Health Dis; 2018 Dec; 17(1):291. PubMed ID: 30579336
[TBL] [Abstract][Full Text] [Related]
20. Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease.
Zhang LY; Qu XN; Sun ZY; Zhang Y
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):674-680. PubMed ID: 32113823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
